期刊文献+

盐酸氢吗啡酮与盐酸吗啡注射液治疗难治性癌痛效果评价 被引量:8

Efficacy evaluation of hydromorphone hydrochloride and morphine hydrochloride injection in the treatment of refractory cancer pain
暂未订购
导出
摘要 目的 比较盐酸氢吗啡酮与盐酸吗啡注射液治疗难治性癌痛的效果。方法 将160例难治性癌痛患者按照随机数字表法分为研究组与对照组,各80例,研究组给予盐酸氢吗啡酮治疗,对照组给予盐酸吗啡注射液治疗。治疗前后比较两组血清一氧化氮、β-内啡肽、前列腺素E_(2)、5-羟色胺水平,比较两组Ramesay镇静量表、视觉模拟评分法及舒适度评分量表评分,比较两组疼痛缓解情况及不良反应发生情况。结果 治疗后两组一氧化氮、前列腺素E_(2)、5-羟色胺水平较治疗前显著降低(P<0.01),β-内啡肽水平较治疗前显著升高(P<0.01),研究组较对照组变化更显著(P<0.01);治疗后两组Ramesay镇静量表及舒适度评分量表评分均显著高于治疗前(P<0.01),视觉模拟评分法评分显著低于治疗前(P<0.01),研究组较对照组变化更显著(P<0.01)。研究组疼痛总缓解率显著高于对照组(P<0.01),两组不良反应发生率比较差异无统计学意义(P>0.05)。结论 盐酸氢吗啡酮治疗难治性癌痛的镇静及镇痛效果较盐酸吗啡注射液更好,可以有效调节疼痛指标水平,缓解疼痛,安全性高,值得临床应用。 Objective To compare the effects of hydromorphone hydrochloride and morphine hydrochloride injection in the treatment of refractory cancer pain.Methods A total of 160 patients with refractory cancer pain were divided into study group and control group according to random number table method,with 80 cases in each group.The study group was treated with hydromorphone hydrochloride,and the control group was treated with morphine hydrochloride injection.The levels of serum nitric oxide(NO),beta-endorphin(β-EP),prostaglandin E_(2)(PGE_(2))and serotonin(5-HT)were compared between the two groups before and after treatment.The Ramsay sedation scale,visual analogue scale(VAS)and Bruggrmann comfort scale(BCS)were compared between the two groups,and the pain relief and adverse reactions were compared between the two groups.Results After treatment,the levels of NO,PGE_(2) and 5-HT in the two groups were significantly lower than those before treatment(P<0.01),and the levels ofβ-EP were significantly higher than those before treatment(P<0.01).The changes in the study group were more significant than those in the control group(P<0.01).After treatment,the Ramsay sedation scale and BCS scores of the two groups were significantly higher than those before treatment(P<0.01),and the VAS scores were significantly lower than those before treatment(P<0.01).The changes in the study group were more significant than those in the control group(P<0.01).The total pain relief rate in the study group was significantly higher than that in the control group(P<0.01),and there was no significant difference in the incidence of adverse reactionsbetween the two groups(P>0.05).Conclusions Hydromorphone hydrochloride has better sedative and analgesic effects than morphine hydrochloride injection in the treatment of refractory cancer pain.It can effectively regulate the level of pain indicators, relieve pain, and has high safety. It is worthy of clinical application.
作者 马英梅 苏培培 李明峰 Ma Yingmei;Su Peipei;Li Mingfeng(The First Affiliated Hospital of Henan University,Kaifeng 475001,Henan,China)
出处 《临床心身疾病杂志》 CAS 2022年第5期128-131,共4页 Journal of Clinical Psychosomatic Diseases
基金 开封市科技发展计划项目(编号2103022)。
关键词 难治性癌痛 盐酸氢吗啡酮 盐酸吗啡注射液 镇静 镇痛 refractory cancer pain hydromorphone hydrochloride morphine hydrochloride injection sedation analgesia
  • 相关文献

参考文献17

二级参考文献174

  • 1王樱,李伟彦,王俊华,孙睿.羟考酮、芬太尼对患者呼吸抑制的临床观察[J].医学信息(医学与计算机应用),2014,0(14):301-302. 被引量:7
  • 2李平,徐萌,郭良君,郑坚,廖倚萍,李丽莎.硫酸吗啡控释片与硫酸吗啡缓释片对重度癌痛患者镇痛效果的比较(英文)[J].中国临床康复,2005,9(6):178-180. 被引量:5
  • 3Quigley c, wiffen P. A systematic review of hydromor- phone in acute and chronic pain. J Pain Symptom Manage, 2003, 25:169 - 178.
  • 4Murray A, Hagen NA. Hydromorphone. J Pain Symptom Manage, 2005, 29:$57 - 66.
  • 5Moore KT, St-Fleur D, Marricco NC, et al. Steady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study inhealthy volunteers. J Opioid Manag, 2010, 6:351 - 358.
  • 6Vandenbossche J, Richarz U, Richards HM. Repeat- dose steady-state pharmacokinetic evaluation of once- daily hydromorphone extended-release (OROS(~) hydromorphone ER) in patients with chronic pain. J Pain Res. 2012, 5:523 - 533.
  • 7Felden L, Walter C, Harder S, et al. Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth, 2011,107:319-328.
  • 8Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging, 2010, 27:417 - 433.
  • 9Wright AW, Mather LE, Smith MT. Hydromorphone- 3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.Life Sci, 2001,69:409 - 420.
  • 10Durnin C, Hind ID, Ghani SP, et al. Pharmacokinetics of oral immediate-release hydromorphone (DilaudidlR) in subjects with moderate hepatic impairment. Proc West PharmacolSoc, 2001, 44:83 - 84.

共引文献402

同被引文献73

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部